MedTrace Logo

Effect of an EAA/Whey Composition on Protein Metabolism

NCT03502941 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2021-11-02

Study results available
· View outcomes & findings →

Summary

Sarcopenia, a progressive loss of muscle mass, strength and function, is an inevitable natural process of aging. While it may be impossible to completely reverse the progress of sarcopenia, it is well established that intake of dietary protein through essential amino acids (EAAs) and whey protein increases anabolic response. The current study will test if a specially formulated mixture of EAAs and whey protein can maximally stimulate anabolic responses at the levels of whole body and muscle compared to whey protein alone.

Conditions

Interventions

DIETARY_SUPPLEMENT

12.6 g of EAAs mixture and whey protein isolate

A double dose of the mixture of EAAs/whey

DIETARY_SUPPLEMENT

12.6 g of whey protein isolate

Whey protein isolate alone, which is an equal amount to the double dose of the mixture of EAAs/whey

DIETARY_SUPPLEMENT

6.3 g of EAAs mixture and whey protein isolate

A single dose of the mixture of EAAs/whey

Sponsors & Collaborators

  • University of Arkansas

    lead OTHER

Principal Investigators

  • Arny A Ferrando, Ph.D. · University of Arkansas

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-20
Primary Completion
2019-04-09
Completion
2019-07-17

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03502941 on ClinicalTrials.gov